LBA3 Transarterial chemoembolization (TACE) with or without lenvatinib (len) + pembrolizumab (pembro) for intermediate-stage hepatocellular carcinoma (HCC): Phase III LEAP-012 study
2024 · Annals of Oncology · 29 citations
https://doi.org/10.1016/j.annonc.2024.08.2277